Cetera Investment Advisers »

Urogen Pharma shares owned by Cetera Investment Advisers

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Cetera Investment Advisers from 13F filings

Historical chart of Cetera Investment Advisers investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Cetera Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Cetera Investment Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $640k 32k 19.95
2025-06-30 $361k 26k 13.70

More positions owned by Cetera Investment Advisers

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
Vanguard Index Fds Value Etf (VTV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Growth Etf (VUG)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Ishares Tr Core Msci Eafe (IEFA)
Amazon (AMZN)

View all positions for Cetera Investment Advisers

Top funds holding Urogen Pharma

Rtw Investments
Paradigm Biocapital Advisors
Toronto-Dominion Bank
BlackRock
Morgan Stanley
Leucadia National Corporation
Silverarc Capital Management
Millennium Management
Acorn Capital Advisors
SG Americas Securities
Menora Mivtachim Holdings
Caption Management
Tang Capital Management
D. E. Shaw & Co
State Street Corporation

View all funds holding Urogen Pharma